This is not the most recent version of the article. View current version (18 APR 2012)

Intervention Protocol

Angiotensin receptor blockers for heart failure

  1. Phillip Jong1,*,
  2. Catherine Demers2,
  3. Robert S McKelvie3,
  4. Peter Liu4

Editorial Group: Cochrane Heart Group

Published Online: 23 APR 2001

DOI: 10.1002/14651858.CD003040


How to Cite

Jong P, Demers C, McKelvie RS, Liu P. Angiotensin receptor blockers for heart failure (Protocol). Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD003040. DOI: 10.1002/14651858.CD003040.

Author Information

  1. 1

    University of Toronto, Toronto, Canada

  2. 2

    McMaster Clinic 3rd Floor, HHSC - General Hospital, Hamilton, Ontario, Canada

  3. 3

    Hamilton Health Sciences Corporation, Heart Function Clinic, Hamilton, Ontario, Canada

  4. 4

    University of Toronto, Toronto General Hospital, Toronto, Ontario, Canada

*Phillip Jong, University of Toronto, 44 St. Joseph Street, Suite 1908, Toronto, M4Y 2W4, Canada. philip.jong@sympatico.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 APR 2001

SEARCH

This is not the most recent version of the article. View current version (18 APR 2012)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  • To determine the efficacy of ARBs on the survival of patients with heart failure when compared to placebo or ACEIs.
  • To determine the efficacy of ARBs on hospitalization rates in patients with heart failure when compared to placebo or ACEIs.